TrialAnnals of oncology : official journal of the European Society for Medical Oncology2025

Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial.

A Tripathi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.